Axim Biotechnologies annual free cash flow
2014
2015
2016
2020
2021
2022
2023
Axim Biotechnologies Free Cash Flow (FCF) History (AXIM)
Axim Biotechnologies reported −$1.0M in free cash flow for fiscal 2023, an increase of $1.0M from the previous fiscal year, with a free cash flow margin of −2607.67%.
View full Axim Biotechnologies company overviewAxim Biotechnologies free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$1.0M | $1.0M | — | −2607.67% |
| 2022 | 2022-12-31 | −$2.1M | $474,224 | — | −23132.80% |
| 2021 | 2021-12-31 | −$2.5M | $785,763 | — | −4180.05% |
| 2020 | 2020-12-31 | −$3.3M | −$2.0M | — | — |
| 2016 | 2016-12-31 | −$1.3M | $261,818 | — | −2750.04% |
| 2015 | 2015-12-31 | −$1.6M | −$1.2M | — | −3166.44% |
| 2014 | 2014-12-31 | −$338,999 | — | — | — |
Axim Biotechnologies quarterly free cash flow
Q3.22
Q1.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q1 2024 | 2024-03-31 | −$255,345 | — | — | −481.97% |
| Q3 2022 | 2022-09-30 | −$323,935 | — | — | −24652.59% |
Axim Biotechnologies free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$1.6M to −$1.0M, a net increase of $525,459. Axim Biotechnologies's latest reported quarter, Q1 2024, generated −$255,345 in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Axim Biotechnologies filings at SEC.gov ↗